Table 2 Postoperative plasma lipid and lipoprotein levels in consecutive 5-year periods in statin-treated patients undergone CABG

DSDI

0.07 ± 0.23

0.46 ± 0.53

1.25 ± 1.19

2.52 ± 1.52

<0.0001

T-C (mmol/l)

5.70 ± 1.27

4.86 ± 1.00

4.20 ± 0.91

3.76 ± 0.82

<0.0001

LDL-C (mmol/l)^b

3.70 ± 1.09

2.94 ± 0.85

2.35 ± 0.72

2.07 ± 0.64

<0.0001

HDL-C (mmol/l)

1.02 ± 0.29

1.12 ± 0.33

1.24 ± 0.32

1.22 ± 0.34

<0.0001

T-G (mmol/l)

2.20 ± 1.22

1.79 ± 0.96

1.56 ± 0.81

1.40 ± 0.65

<0.0001

VLDL-TG (mmol/l)

1.36 ± 0.85

1.12 ± 0.79

0.95 ± 0.6

0.85 ± 0.

<0.0001

IDL-C (mmol/l)

0.38 ± 0.14

0.28 ± 0.11

0.23 ± 0.11

0.23 ± 0.16

<0.0001

LDL-C (mmol/l)

3.55 ± 0.78

3.01 ± 0.71

2.49 ± 0.63

2.21 ± 0.51

<0.0001

HDL-2-C (mmol/l)

0.57 ± 0.23

0.67 ± 0.27

0.76 ± 0.27

0.77 ± 0.28

<0.0001

HDL-3-C (mmol/l)

0.46 ± 0.07

0.47 ± 0.07

0.48 ± 0.07

0.48 ± 0.07

0.0121

ApoA1 (g/l)

1.38 ± 0.22

1.38 ± 0.24

1.42 ± 0.24

1.37 ± 0.26

0.1864

ApoB (g/l)

1.30 ± 0.26

1.09 ± 0.26

0.90 ± 0.23

0.81 ± 0.18

<0.0001